Sofinnova Partners — Full Portfolio

Hemab develops targeted therapies for bleeding and clotting disorders such as Glanzmann thrombasthenia, Factor VII deficiency, Von Willebrand Disease, and heavy menstrual bleeding.

BiotechDigital HealthHealthtechMedical Devices

Co-investorsACAccess BiotechnologyAVAvoro Capital AdvisorsHEHealthCapNONovo HoldingsAVAvoro VenturesRARA Capital

MaxCyte develops non-viral electroporation and cell-engineering technology used to transfect and engineer cells for research and therapeutic development.

BiotechDeep TechMedical DevicesGaithersburg, US

Douglas A. Doerfler(Executive Officer, Director)MVMadhusudan V Peshwa(Executive Officer)Ronald E. Holtz(Executive Officer, Director)Thomas Ross(Executive Officer)Karen Donato(Executive Officer)

BoardWilliam Brooke(Director)

Quince Therapeutics is a biotechnology company developing the AIDE technology platform, a drug/device combination that encapsulates medications into a patient's own red blood cells to improve drug delivery for rare diseases.

BiotechSouth San Francisco, US

Stephen Dominy(Director)Casey Lynch(Executive Officer, Director)Charles Ryan(Executive Officer)inBrendan Hannah(Executive Officer)DTDirk Thye(Executive Officer, Director)inKristen Gafric(Executive Officer)

Co-investorsFOForesite CapitalTATakeda Ventures

6WIND is a technology company focused on internet and telecommunications infrastructure, backed by major investors including NVIDIA and Cisco.

Cloud ComputingCybersecurityData & InfrastructureEnterprise SoftwareMontigny-le-Bretonneux, FR

JDJulien Dahan(Chief Executive Officer)in

Co-investorsCICisco InvestmentsINInnovation CapitalNVNVIDIA

Biotech

Co-investorsKUKurma PartnersJOJohnson & Johnson Innovation – JJDCM M VenturesSRSR One Capital ManagementEQEQT Life Sciences

ASSIA develops core technology for broadband internet access and network optimization, serving telecommunications service providers and network operators.

AI & Machine LearningCloud ComputingData & InfrastructureDeep TechEnterprise SoftwareRedwood City, US

JMJohn M. Cioffi(CEO and Chairman of the Board)inACAssia Cioffi(Executive Vice President and Co-founder)in

Co-investorsDTDTCPSOSofinnova VenturesSTStanford UniversitySWSwisscom VenturesPAPartners for GrowthPAPartners for Growth (PFG)

BioCorteX develops personalized therapeutics using a microbiome knowledge graph and proprietary biology emulation platform to tailor drug treatments for diverse populations.

AI & Machine LearningBiotechDigital HealthMedical Devices

Co-investorsHOHoxton VenturesDRDraper Associates

Bionyra Pharma is a clinical-stage biopharmaceutical company developing next-generation mono and multispecific antibodies for severe immune-mediated inflammatory diseases, with an initial focus on atopic dermatitis and inflammatory bowel disease.

BiotechHealthtech

FMFrédéric Marrache(Co-founder & CEO)in

Co-investorsJEJeito CapitalSASanofi VenturesVIVIVES PartnersAPApollo Health VenturesSISixty Degree Capital

Crescendo Biologics develops novel immune cell-enhancing therapeutics for immuno-oncology using its patent-protected Humabody VH platform, a fully human domain technology clinically validated in oncology and immunology.

BiotechHealthtechMedical Devices

Co-investorsANAndera PartnersQUQuan CapitalASAstellas Venture Management LLCEMEMBL VenturesFUFuture Planet CapitalAVAvlar BioVentures+1 more

Elevara Medicines is a clinical-stage biotech developing ELV001, a first-in-class once-daily oral CDK4/6 inhibitor that targets fibroblast-like synoviocytes as an add-on therapy for rheumatoid arthritis and other chronic inflammatory diseases.

BiotechHealthtechMedical DevicesLondon, GB

Emma Tinsley(Founder & former CEO (now Non-Executive Director))inMZMai-Britt Zocca(CEO)in

Co-investorsMOMonograph Capital PartnersFOForbion

Enthera Srl is a privately held pharmaceutical company founded in 2016 and based in Milan, Italy.

BiotechHealthtechMilan, IT

Co-investorsINIndaco Venture PartnersRORoche Venture FundABAbbVieJDJDRF T1D Fund

Enyo Pharma is a biotechnology company focused on drug development in the life sciences and therapeutics field.

BiotechHealthtechMedical DevicesLyon, FR

JVJacky Vonderscher(Co-founder & CEO)inLaurène Meyniel-Schicklin(Founder, Head of Bioinformatics)inBDBenoît de Chassey(Founder, Head of Drug Discovery Platform)inPatrice André(Founder, Medical Advisor)inVincent Lotteau(Founder, Advisor)JGJean-Jacques Garaud(Co-founder)in

Co-investorsANAndera PartnersOROrbiMedBPBpifrance

Excelsior Sciences develops automated chemistry technology for small-molecule discovery and manufacturing, targeting pharmaceutical and materials development.

AI & Machine LearningBiotechDeep Tech

Marty BurkeBartosz GrzybowskiMFMichael Foley(CEO)inJJJana Jensen(COO)in

Co-investorsKHKhosla VenturesCOCornucopian Capital ManagementILIllinois VenturesDEDeerfield Management Company

Genespire is a life sciences company backed by multiple venture capital investors including Sofinnova Partners, XGEN Venture, CDP Venture Capital, and Indaco Venture Partners.

BiotechDeep TechDigital HealthHealthtech

DLDr. Lucia Faccio(Chief Executive Officer)inDJDr. Julianne Smith(Chief Development Officer)DSDr. Simon Hawkins(VP Clinical Development)DSDr. Smaragda Angelidou(Responsabile CMC)DMDr. Mary Wang(Patient Engagement Director)EBEmanuela Balzo(VP of Finance)in

Co-investorsCDCDP Venture CapitalINIndaco Venture PartnersXGXGEN Venture

HAYA Therapeutics develops precision RNA medicines that target long non-coding RNAs (lncRNAs) in the regulatory genome to reprogram disease at the level of cell state, with a lead program in cardiac fibrosis and work in obesity and metabolic disease.

AI & Machine LearningBiotechDeep TechHealthtech

SOSamir Ounzain(Chief Executive Officer (CEO) & Co-founder)inDBDaniel Blessing(Chief Scientific Officer (CSO) & Co-founder)inRLRichard Law(Chief Business Officer (CBO))inEAEric Adam(Chief Operating Officer (COO))inJSJordan Shin(Chief Medical Officer (CMO))inJAJérôme Andries(Chief Financial Officer (CFO))in

Co-investorsBRBroadview VenturesAPApollo Health Ventures+N+ND Capital4S4see VenturesHUHumboldt

HighLife develops a transcatheter mitral valve replacement (TMVR/TSMVR) technology for patients with moderate to severe mitral regurgitation, implanted in a beating heart while preserving the native valve structure.

BiotechHealthtechMedical DevicesParis, FR

GBGeorg Börtlein(Founder)inMNMalek Nasr(Founder)inRLRüdiger Lange(Founder (Heart Surgeon))Nicolo Piazza(Founder (Interventional Cardiologist))SPStefan Pilz(CEO)inSBStephen Brecker(Chief Medical Officer)in

Co-investorsANAndera PartnersUSUS Venture PartnersVIVI Partners

Home Biosciences was a venture builder in Continental Europe dedicated to creating and scaling biotech companies through an asset-centric, hub-and-spoke model, working with academics and scientists on drug discovery and molecular profiling projects.

AI & Machine LearningBiotechHealthtech

DSDavid Schilansky(Co-founder & Non-executive Chairman)inMagali Richard(Co-founder)in

Co-investorsREREDMILE

Inspirna is a clinical-stage biopharmaceutical company developing novel cancer drugs that target previously undruggable drivers of metastasis using its proprietary miRNA-DRIVEr platform.

BiotechHealthtechMedical DevicesNew York, US

Sohail Tavazoie(Co-Founder & Chair of Scientific Advisory Board)Masoud Tavazoie(Co-Founder & Advisor)in

Co-investorsVIVivo CapitalSASands Capital VenturesSTStart CapitalNONovo Holdings

Leucid Bio develops CAR-T cell therapies based on a proprietary Lateral CAR platform that redesigns the CAR structure to mimic the lateral signalling arrangement of natural immune receptors.

BiotechHealthtechLondon, GB

JMJohn Maher(Founder)

Co-investorsVUVulpes Investment ManagementEPEpidarex Capital

May Health develops medical technology solutions for women with polycystic ovary syndrome and PCOS-related infertility.

FemTechHealthtechMedical DevicesParis, FR

Anne Morrisseyin

BoardColby HoltshouseHugh E. Magen

Co-investorsBPBpifrance

Microphyt develops microalgae-based ingredients and products for nutrition, dietary supplements, and personal care using proprietary bio-reactor technology.

BiotechFoodTechHealthtechNew MaterialsWellness & Fitness

Arnaud Muller-FeugaVUVincent Usache(Managing Director)in

Co-investorsBPBpifranceSUSupernova Invest

Moon Surgical develops the Maestro robotic surgery system, a digital surgical robotics platform used by surgeons to perform procedures.

HealthtechMedical DevicesRoboticsParis, FR

BGBrice Gayet(Founder)inAOAnne Osdoit(Chief Executive Officer)inEEEric Ermenault(Chief Commercial Officer)inARAnne Renevot(Chief Financial Officer)inVFViola Fleig(Chief Operations Officer)inDNDavid Noonan(Chief Technology Officer)in

Co-investorsNVNVIDIACACathay HealthJOJohnson & Johnson Innovation – JJDCNVNVentures

NanoPhoria is a life sciences company that raised an €83.5 million Series A round.

BiotechDeep TechMedical Devices

DCDaniele CatalucciinMIMichele IafiscoAAAlessio AlognaCDClaudio De Lucain

Co-investorsXGXGEN VentureCDCDP Venture CapitalEUEuropean Innovation Council Fund

Nuage Therapeutics develops drug discovery technologies for disordered proteins, focusing on precision treatments for aggressive cancers with limited therapeutic options.

AI & Machine LearningBiotechDeep TechBarcelona, ES

MBMateusz Biesaga(Founder and Chief Technology Officer)inXSXavier Salvatella(Founder)in

Co-investorsASAsabys PartnersBSBStartup

Latent Labs develops AI tools for drug discovery and design, enabling biotech and pharmaceutical companies to accelerate therapeutic molecule identification.

AI & Machine LearningBiotechDeep TechHealthtech

SKSimon Kohl(Founder)in

Co-investorsKIKindredPIPillarRARadical VenturesPEPetri

Purespring develops genetic therapies targeting podocytes to treat renal diseases through its proprietary GlomThera platform.

BiotechDigital HealthHealthtechMedical Devices

MSMoin Saleem(Co-founder & Chief Scientific Advisor)in

Co-investorsFOForbionGIGilde HealthcareADAdvent Life SciencesBRBritish Patient Capital

SafeHeal is a medical device manufacturer developing anastomosis protection devices for colorectal surgery.

BiotechDigital HealthHealthtechMedical DevicesFrance, FR

CRChris Richardson(President & CEO)inKBKarl Blohm(VP, International)inScott DePierro(VP, US Operations)inMVMarcos Velez-Duran(VP, Regulatory Affairs and Quality)inBMBrent Metzler(CFO)MAMichael Augelli(VP, R&D, Manufacturing)in

Co-investorsASAsabys Partners

Sitryx is a biotechnology company, founded in 2018, developing therapeutics with a focus on immunometabolism.

BiotechDeep TechHealthtech

Co-investorsLOLongwood FundOXOxford Science EnterprisesSVSV Health Investors

Galvanize Therapeutics develops surgical ablation technology using its proprietary Aliya Pulsed Electric Field (PEF) energy to destroy soft tissue cells through regulated cell death mechanisms.

BiotechHealthtechMedical DevicesRedwood City, US

DGDoug Godshall(Executive Officer, Director)inSASteve Anheier(Executive Officer)in

BoardJonathan Waldstreicher(Executive Officer)APAntoine Papiernik(Director)inSeth Harrison(Director)ZSZack Scott(Director)in

Board seatAPAntoine Papiernik Papiernik· per SEC Form D

Co-investorsNONorwest Venture PartnersALAlly Bridge GroupATATPFIFidelity InvestmentsGIGilmartin Capital LLCJAJanus Henderson Investors+2 more

Mediartx develops novel therapies for patients with fibrotic diseases.

BiotechMedical DevicesBoston, US

Rahul Ballal, PhD(CEO)PYPaul Yaworsky, PhD(CSO)inRBRahul Ballal(Executive Officer, Director)inBrian Hubbard(Director)Stacey Brenner(Executive Officer)David de Graaf(Director)

Board seatMBMaina Bhaman· per SEC Form D

Co-investorsAGAgent CapitalLOLongwood FundMIMission BiocapitalNONovartis Venture FundONOno Venture Investment, Inc.PFPfizer Venture Investments+3 more

RefleXion Medical develops SCINTIX autonomous radiotherapy, an external beam theranostic oncology platform that uses biological signals from radiopharmaceutical-labeled cancer cells to deliver real-time, motion-managed radiation to lung and bone tumors from primary or metastatic disease.

BiotechHealthtechMedical DevicesHayward, US

Samuel Mazin(Executive Officer, Director)inAkshay Nanduri(Executive Officer, Director)in

BoardJWJay Watkins(Director)in

Board seatAPAntoine Papiernik Papiernik· per SEC Form D

Co-investorsASAscension VenturesCACatalio Capital Management, LPPFPfizer Venture InvestmentsSOSonder CapitalVEVenrockSOSonder Futures

BiotechNew York, US

MTMasoud Tavazoie(Chief Scientific Officer)DDDavid Darst(Chief Operating Officer)IKIsabel Kurth(Vice President - Research)

BoardShahram Seyedin-Noor(Executive Chairman)Nancy Chang(Director)

Board seatAPAntoine Papiernik Papiernik· per SEC Form D

Co-investors+N+ND CapitalOCOceanpine Capital

Shockwave Medical develops intravascular lithotripsy (IVL) catheter systems used to treat calcified cardiovascular disease, marketed to interventional cardiologists and vascular specialists.

HardwareHealthtechMedical DevicesFremont, US

DHDaniel Hawkins(Executive Officer, Director)inTJTodd J. Brinton(Director)inIIsaac(President)

BoardJWJay Watkins(Director)inAPAntoine Papiernik(Director)inFrederic H. Moll(Director)

Board seatAPAntoine Papiernik Papiernik· per SEC Form D

Co-investorsSOSonder CapitalVEVenrockSESectoral Asset Management

Co-investorsNENeva Sgr.XGXGEN VentureATAtlas VentureFOForbionLOLongwood Fund

ABIONYX Pharma is a biotech company developing therapies for diseases with no effective or existing treatment, including rare conditions.

Biotech

Abivax develops obefazimod, an orally administered small molecule drug candidate with a novel mechanism of action targeting microRNA biology to treat chronic inflammatory diseases including ulcerative colitis and Crohn's disease.

BiotechHealthtechMedical DevicesParis, FR

MDMarc de Garidel(CEO)in

Co-investorsANAndera PartnersCLClaret Capital PartnersMEMedicxiSASamsara BioCapitalTRTruffle CapitalMOMorgan Stanley

Actithera develops a chemistry platform for targeted cancer treatment that optimizes radiation dose absorption in tumors while reducing exposure to healthy tissue, with flexibility to pair different radionuclides based on tumor characteristics.

AI & Machine LearningBiotechDeep TechHealthtechMedical Devices

Darshan Dalal(Chief Medical Officer)in

Co-investorsHAHadean VenturesM M Ventures4B4BIO CapitalBIBioqube Ventures

Afyren produces bio-based organic acids derived from fermentation of non-food biomass to replace petroleum-derived molecules in consumer products and industrial applications.

BiotechCircular EconomyCleantech

Nicolas Sordet(Co-founder)inJPJérémy Pessiot⚡(Founder)in

Co-investorsSUSupernova Invest

Alia Therapeutics is a biotech company developing therapeutics based on gene-editing technology.

BiotechDeep TechHealthtech

Co-investorsINIndaco Venture Partners

Artios develops DNA damage response (DDR)-based medicines targeting patients with high unmet need cancers.

BiotechHealthtechMedical Devices

Co-investorsANAndera PartnersM M VenturesNONovartis Venture FundPFPfizer Venture InvestmentsRARA CapitalSVSV Health Investors+2 more

Arzeda designs proteins and metabolic pathways using computational tools, including its Archytas protein design software and Scylax metabolic pathway design software.

AI & Machine LearningBiotechDeep TechFoodTechNew MaterialsSeattle, US

AZAlexandre Zanghellini(Co-Founder & Chief Executive Officer)inEAEric Althoff(Executive Officer, Director, Promoter)inDBDavid BakerBBBill Baum(Director)inAndrew Ban(Executive Officer)Daniela Grabs(Executive Officer)

Co-investorsCICirculate CapitalSUSustainable Conversion VenturesCOContinental Grain CompanyFAFall Line CapitalLELewis & Clark AgriFoodOSOS Fund+1 more

Avantium develops bio-based materials and polymer technologies, including PEF and other renewable alternatives to conventional plastics, serving the packaging and materials industry.

BiotechCircular EconomyCleantechNew MaterialsNetherlands, NL

Co-investorsNANavitas CapitalASAster CapitalCACapricorn Venture PartnersNVNV NOMPMPMVSISignet Healthcare Partners+2 more

BioClec is a Milan-based discovery-stage biotech developing microglia-targeting therapies for Alzheimer's disease and dementia, launched from Sofinnova Partners' Biovelocita II accelerator.

Milano, IT

Bioptimus is an AI-first biotech company developing a universal AI foundation model that connects biology across scales, from molecules and cells to tissues and whole organisms, to support biomedical research and innovation.

AI & Machine LearningBiotechDigital HealthHealthtechParis, FR

EDEric Durand(Founder)inFLFelipe Llinares-López(Co-founder & VP of AI)inRJRodolphe Jenatton(Co-founder & CTO)inZMZelda Mariet(Co-founder & VP of Research)inJean-Philippe Vert(Co-founder & CEO)inDCDavid Cahané(Co-founder & General Manager)

Co-investorsANAndera PartnersCACathay InnovationFEFELIX CAPITALFRFrstHEHeadlineHEHeadline Growth Management, LLC+3 more

Biosyntia is a Copenhagen-based industrial biotech company that uses strain engineering and fermentation to produce sustainable, bio-based active ingredients like vitamin B7, replacing petrochemical-derived alternatives for cosmetics and nutrition markets.

Copenhagen, DK

Co-investorsEUEuropean Circular Bioeconomy FundNONovo Holdings

Biotalys develops protein-based biocontrol products for crop protection, giving farmers tools to prevent crop loss and extend post-harvest protection while reducing food waste.

AgTechBiotechFoodTechGhent, BE

Co-investorsAGAgri Investment FundPMPMV

Borea Therapeutics develops gene therapy delivery technologies based on a proprietary AAV conjugation platform targeting neurological and genetic diseases.

BiotechDeep TechHealthtechMedical Devices

PHPaul Heppenstall(Scientific Co-Founder)NBNiccolò Bacchi(CEO)in

BrightHeart develops the B-Right AI Platform, an AI system that analyzes routine prenatal ultrasound images and clips to help clinicians and sonographers detect signs of congenital heart defects and confirm fetal heart scan completeness.

AI & Machine LearningDigital HealthHealthtech

Co-investorsLLLLR

Calliditas is a biopharmaceutical company developing and commercializing treatments for renal and other conditions, including TARPEYO/Nefecon/Kinpeygo (budesonide) for primary IgA nephropathy and NOX inhibitor candidates such as setanaxib for fibrotic diseases and cancer.

BiotechHealthtechMedical DevicesStockholm, SE

Co-investorsINIndustrifondenKRKreos Capital

Catamaran Bio develops allogeneic CAR-NK cell therapies for cancer treatment, focusing on solid tumors, by combining natural killer (NK) cell biology with synthetic biology and non-viral cell engineering.

BiotechHealthtech

BMBranden Moriarity(Scientific Co-founder)Catherine Bollard(Scientific Co-founder)

Co-investorsASAstellas Venture Management LLCLILightstone Ventures

CelluComp develops sustainable, cellulose-based bio-composite materials for packaging applications, serving consumer goods and packaging companies seeking environmentally responsible alternatives.

Advanced ManufacturingCircular EconomyCleantechNew MaterialsScotland, GB

Dr. Eric Whale(Founder and Head of Technology)Dr. David Hepworth(Founder)CKChristian Kemp-Griffin(CEO)in

Co-investorsSCScottish Enterprise

Cambridge, US

ENEJ KUSCER, PH.D.(Executive Officer)PETER VAN VLASSELAER, PH.D.(Director)HENRIJETTE RICHTER, PH.D.(Director)BERNARDUS MACHIELSE(Director)LUCAS DE BREED(Director)DAVID DE GRAAF, PH.D.(Executive Officer, Director)

Co-investorsMIMission BiocapitalCACanaan Partners

CorVent Medical develops medical ventilators, including the RESPOND ventilator, that provide ICU-standard respiratory support for acute and post-acute patients.

HardwareHealthtechMedical DevicesFargo, US

MTMurphy Travis(Executive Officer)inJNJeremy Nelson(Executive Officer)inRSRichard S. Walsh(Executive Officer, Director)inJOJohn O'Mahony(Executive Officer)inRob Faulkner(Director)Lukas Geunther(Director)

CorWave produces a ventricular assist pump for advanced heart failure patients, delivering pulsatile flow to provide mechanical cardiac support for transplant candidates, non-transplant-eligible patients, and recovery cases.

BiotechDeep TechHealthtechMedical Devices

LDLouis de Lillers(CEO)inAFAndreas Fleischli(CTO)in

Co-investorsYSYsios Capital

Cure51 is a cancer research company that decodes the biology of exceptional cancer survivors ("cancer outliers") using molecular profiling and computational biology, collecting patient data on its Patient Profile Platform.

AI & Machine LearningBiotechDigital HealthHealthtech

PCPaloma Cejas(Founder, Head of Translational Research)inRNRémy Nicolle(Founder, Senior Advisor Computational Biology)

Co-investorsHIHitachi VenturesKIKima VenturesLILifeX Ventures

An AI radiology platform that automates the reporting process and hosts 80+ leading imaging AI vendors.

Co-investorsMEMeridian Health Ventures

DMC Biotechnologies is a U.S.-based biomanufacturer that uses precision fermentation and its Dynamic Metabolic Control platform to produce bio-based specialty chemicals and ingredients, such as L-alanine and fermented inositols.

BiotechClimate TechNew MaterialsBoulder, US

Matthew Lipscomb(Director)Josh Yelen(Executive Officer)JFJim Flatt(Executive Officer, Director)in

BoardJosko Bobanovic(Director)RVRob van der Meij(Director)inAlastair Cooper(Director)

Co-investorsBRBreakthrough Energy VenturesBOBoulder VenturesCACapricorn Venture Partners

Elicit Plant develops agricultural solutions that trigger plants' natural defenses to help field crops resist water stress and adapt to climate change.

AgTechBiotechClimate Tech

Olivier Goulay(Founder)in

Co-investorsEUEuropean Circular Bioeconomy Fund

Endoron Medical develops transcatheter anchoring and sealing devices for aortic procedures, including Aortodock (a nitinol docking system to stabilize transcatheter valves in low-calcium aortic regurgitation and stenosis anatomies) and Aortoseal (a multi-stapling fixation and sealing system for endovascular aneurysm repair grafts).

HardwareHealthtechMedical Devices

Enginzyme develops a technology platform for sustainable chemistry applications aimed at removing carbon dioxide from the atmosphere.

BiotechCleantechClimate TechNew MaterialsStockholm, SE

ADAymeric de Gantès(CEO)inJosefin Lannefors(Chief Commercial Officer)inMAMarco Antonio Saucedo(Chief Technology Officer)in

Co-investorsINIndustrifondenNANavigare Ventures

Extracellular is a biomanufacturing company that helps cell-based product developers in cultivated meat, plant cell culture, and bioactives accelerate discovery, overcome production challenges, and commercialize their products.

Advanced ManufacturingBiotechFoodTechNew Materials

WMWill Milligan(CEO & Founder)in

Co-investorsBIBig Idea VenturesFFFFFNENewland SyndicateUNUnruly Capital5A5AM VenturesAGAgent Capital+8 more

F2G develops medicines to treat serious fungal diseases where existing therapies have failed or are ineffective.

BiotechDigital HealthHealthtechMedical Devices

Co-investorsADAdvent Life SciencesAIAisling CapitalAMAMR Action FundASAstellas Venture Management LLCBRBrace PharmaSUSunstone Capital+3 more

Forth Therapeutics is an Edinburgh/Cambridge-based biotech spinout from the University of Edinburgh developing precision, omics-driven therapeutics to halt or reverse fibrosis across multiple organ systems.

Co-investorsOLOld College Capital

Freya Biosciences develops innovative therapies targeting immune-mediated diseases that affect women.

BiotechFemTechHealthtech

Colleen Acosta, PhD(CEO, Co-Founder)Johan van Hylckama Vlieg, PhD(CSO, Co-Founder)

Co-investorsANAngelini VenturesINIndaco Venture PartnersOMOMX VenturesBIBill & Melinda Gates Foundation

Galvanize provides customized technical education and training programs to help enterprise teams build skills in AI, machine learning, XP and Agile practices, data pipelines, and cloud operations.

AI & Machine LearningEdTechEnterprise SoftwareFuture of WorkDenver, US

Christopher C. Onan(Executive Officer)James Deters(President and Chief Executive Officer)LMLawrence Mandes(Managing Director, New Markets)in

BoardDaniel Pianko(Director)Tatiana Goldstein(Director)Jerrold Miller(Director)

Co-investorsTETeamworthy VenturesTHThe Colorado Impact FundVTVTF CapitalALAlly Bridge GroupCACatalyst InvestorsFIFidelity Investments+5 more

Galvanize Climate Solutions is an investment firm focused on the energy transition, deploying capital across areas such as climate risk analytics and clean energy.

CleantechClimate TechEnergy

VMVeery Maxwell(Founder)in

Co-investorsABABS Capital PartnersBLBlue Haven InitiativeGAGalvanize Climate SolutionsALAlly Bridge GroupFIFidelity InvestmentsGIGilmartin Capital LLC+4 more

GenSight Biologics develops clinical-stage gene therapy treatments, with a lead candidate (GS010/LUMEVOQ) in development for rare genetic diseases.

BiotechDigital HealthHealthtechMedical DevicesParis, FR

Jean-Philippe Combal(Executive Officer)Michael Stephen Wyzga(Director)Thomas Gidoin(Executive Officer)Didier Pruneau(Executive Officer)Florent Gros(Director)Nitza Thomasson(Executive Officer)

Co-investorsABAbingworth

GFBiochemicals develops plant-based chemical ingredients derived from levulinate technology to replace harmful petrochemical components in consumer products such as shampoos, detergents, and cosmetics.

BiotechCircular EconomyCleantechClimate TechNew MaterialsAix en Provence, FR

MFMathieu Flamini(Founder)inPasquale Granata(Founder)in

GlycoEra develops glycan-based therapeutics, applying glycoengineering technology to create biologic drugs.

BiotechHealthtechNewton, US

Ganesh V. Kaundinya(President & CEO)in

Co-investors5A5AM VenturesCACatalio Capital Management, LPLILifeArc VenturesRORoche Venture FundSISixty Degree CapitalAGAgent Capital+1 more

HotSpot Therapeutics develops novel biopharmaceutical products and therapeutic platforms focused on innovative biomedical technologies.

AI & Machine LearningBiotechHealthtech

BoardBBBruce Booth(Chairman)in

Co-investorsATAtlas VentureB B Capital GroupB4B4 CapitalMRMRL Ventures FundSOSolasta VenturesSRSR One Capital Management+1 more

Ingenix builds an AI "Reasoning Engine" using an approach it calls Modality Fusion to integrate biological data across modalities and scales.

AI & Machine LearningBiotechDeep Tech

ADAdam Dancewicz(Founder)

Co-investorsINInovo VCOTOTB VenturesIFIFC

Inventiva is a clinical-stage biopharmaceutical company developing drug candidates, with a focus on liver and other diseases.

BiotechMedical Devices

Co-investorsEUEuropean Investment BankANAndera PartnersCLClaret Capital PartnersNENew Enterprise Associates (NEA)SASamsara BioCapitalBIBiotechnology Value Fund+1 more

iOmx Therapeutics is a biotech company developing novel cancer therapies.

AI & Machine LearningBiotechHealthtechMedical DevicesMunich, DE

Co-investorsM M VenturesMIMIG Capital AG

Julier Medical is a Paris-based, pre-clinical medical device startup developing a mechanical thrombectomy device to remove blood clots and restore blood flow in acute ischemic stroke patients.

The National Kidney Foundation works to eliminate preventable kidney disease, accelerate innovation in patient care, and address structural inequities in kidney treatment and transplantation services.

HealthtechImpact & Social Good

Co-investorsYSYsios CapitalBIBioGeneration VenturesEPEpidarex CapitalRORoche Venture FundSCScottish National Investment Bank

Kiro is a health technology company that transforms healthcare data into actionable intelligence for patients and healthcare providers.

AI & Machine LearningDigital HealthHealthtech

Co-investorsKIKima Ventures

Latent Labs develops generative AI models for protein design and builds biological platforms to validate AI-driven designs.

AI & Machine LearningBiotechDeep TechLondon, GB

SKSimon Kohl(CEO / Team Lead)in

Co-investors8V8VCFLFlying Fish VenturesISIsomer CapitalKIKindred CapitalPIPillar VCRARadical Ventures

LimFlow develops a medical device system for the treatment of chronic limb-threatening ischemia.

HealthtechMedical Devices

Co-investorsLOLongitude Capital

HealthtechPlymouth, US

Dan Sachs(Director)PCPeter Crosby(Executive Officer, Director)inJason Hannonin

BoardManus Rogan(Director)inAPAntoine Papiernik(Director)in

Co-investorsFOFountain Healthcare PartnersALAlly Bridge GroupGIGilde HealthcareVIViking Global Investors

Meiogenix develops a proprietary recombination technology that targets meiotic recombination to accelerate genetic gain and variety development in crops.

AgTechBiotechDeep Tech

Ricardo Garcia de Albain

Co-investorsGEGenoa VenturesKUKurma PartnersCACasdin Capital

Micropep develops natural crop protection solutions using micropeptides—short protein molecules that regulate plant genes and proteins—for farmers seeking sustainable alternatives.

AgTechAI & Machine LearningBiotechClimate TechToulouse, FR

TLThomas Laurent(Founder & Strategic Advisor)inGGGeorg Goeres(Chief Executive Officer)inMikael Courbot(Chief Technology Officer)in

Co-investorsSUSupernova InvestFAFall Line CapitalZEZebra Impact Ventures

Mironid is a drug development company building a pipeline of therapies targeting cAMP-degrading phosphodiesterase enzymes to treat Autosomal Dominant Polycystic Kidney Disease (ADPKD) and other rare kidney diseases.

BiotechMedical Devices

ARAdele Rowley(Chief Scientific Officer)in

Co-investorsEPEpidarex CapitalRORoche Venture FundBIBioGeneration VenturesSCScottish National Investment Bank

Mission Therapeutics develops therapeutics targeting deubiquitylating enzymes (DUBs), such as USP30, which regulate ubiquitylation and processes including mitophagy and protein homeostasis.

BiotechHealthtech

Co-investorsPFPfizer Venture InvestmentsRORoche Venture FundSRSR One Capital Management

Mnemo Therapeutics is a Paris-based clinical-stage biotech developing cell therapies using its EnfiniT epigenetic antigen discovery platform to target tumor-specific antigens for CAR-T therapies.

Co-investorsALAlexandriaCACasdin CapitalREREDMILE

EdTechBoston, US

Co-investorsTETechstars

Mozart Therapeutics develops protein therapeutics focused on immunology and oncology treatments.

BiotechMedical Devices

MDMark Davis(Scientific Co-Founder)K. Christopher Garcia(Scientific Co-Founder)CKCalvin Kuo(Scientific Co-Founder)KFKatie Fanning(President & Chief Executive Officer)in

Co-investorsARARCH Venture PartnersJDJDRF T1D FundMRMRL Ventures FundONOno Venture Investment, Inc.PFPfizer Venture InvestmentsALAlexandria+4 more

Muna Therapeutics is a biotechnology company developing therapeutics, with a focus on drug discovery involving medicinal chemistry.

BiotechDeep TechHealthtechLongevity

RBRita Balice-Gordon(Founder)inJVJoachim Vilstrup(Head of Protein Chemistry and Structural Biology; scientific co-founder)inMDMichel Detheux(Chief Executive Officer & Board Director)inAHAnders Hinsby(Chief Operating Officer)inNPNiels Plath(Chief Scientific Officer)inJBJakob Busch-Petersen(Chief Development Officer)in

Co-investorsDRDroia VenturesSASanofi VenturesV-V-Bio Ventures

Myricx Bio is a biotech company developing antibody drug conjugates (ADCs) based on N-myristoyltransferases (NMT) inhibitors for cancer treatment.

BiotechMedical DevicesLondon, GB

Co-investorsBRBrandon Capital PartnersNONovo HoldingsABAbingworth

Nephris is a biotech company developing first-in-class therapies for diabetic chronic kidney disease.

BiotechDigital Health

Neurent Medical develops the NEUROMARK system, a radiofrequency ablation device that targets hyperactive autonomic nerves to treat chronic rhinitis symptoms in ENT patients.

HealthtechMedical Devices

Co-investorsATAtlantic Bridge VenturesCLClaret Capital PartnersMVMVM Life Science PartnersENEnterprise IrelandEQEQT Life SciencesFOFountain Healthcare Partners+1 more

Nitrase Therapeutics is a clinical-stage biopharmaceutical company using its NITROME platform to develop therapeutics based on nitrases, a class of enzymes it discovered that drive protein nitration.

BiotechHealthtechLongevity

Irene Griswold-Prenner(Founder & Chief Executive Officer)in

Co-investorsMIMission BiocapitalABAbbVieDEDementia Discovery FundMIMission Bay Capital

NodThera develops clinical-stage small-molecule therapies targeting inflammation for cardiometabolic and neuroinflammatory diseases, including cardiovascular disease, metabolic dysfunction, and neuroinflammation.

BiotechHealthtech

GMGeoff McDonough(Executive Team / Board)inCGChris Guiffre(Executive Team)inAPAlan P. Watt(Executive Team)inJGJyothis George(Chief Medical Officer)inNCNick Clarke(Executive Team)in

Co-investors5A5AM VenturesEPEpidarex CapitalF-F-Prime CapitalSASanofi Ventures

Noema Pharma develops a late-stage portfolio of oral small molecule therapeutics for people with neurological and related disorders, targeting both orphan and larger indications with significant unmet medical needs.

BiotechHealthtechMedical Devices

ILIlise Lombardo(Chief Executive Officer)inVKVolker Knappertz(Executive Vice President of Research & Development)inMSMichael Samar(Chief Financial Officer)inRLRob Lasser(Chief Medical Officer)in

Co-investorsBIBioMedPartnersJEJeito CapitalRORoche Venture FundEQEQTEQEQT Life SciencesFOForbion+2 more

NovaMeat develops plant-based protein food products, positioning them as part of a new culinary tradition.

FoodTech

GSGiuseppe Scionti(Founder)in

Co-investorsAUAurum Venture PartnersCACarbonUNUnovis Asset ManagementVUVU Venture PartnersFOForbionRURubio Impact Ventures

The page is a Vietnamese-language sports streaming site (90Phut TV / 90Phutr.tv, also called Vaoroi TV) offering free live football streaming links, match schedules, standings, results, news, and betting odds.

Media & EntertainmentSports TechHà Nội, VN

Co-investorsAIAisling CapitalM M VenturesNENew Enterprise Associates (NEA)SOSofinnova Ventures

BiotechPrinceton, US

Gerald Wisler(Executive Officer, Director)Christian Schade(Executive Officer)

BoardGSGraziano Seghezzi(Director)inDavid Mott(Director)George Horner(Director)

Co-investorsNENew Enterprise Associates (NEA)

P2 Science develops green chemistry platform technologies (including its PIOz ozonolysis and PICE polymerization processes) that convert renewable, plant-based oils into functional intermediates, specialty ingredients, and polymers.

BiotechCircular EconomyCleantechNew MaterialsWoodbridge, US

PAPaul Anastas(Co-founder)Patrick Foley(Co-founder & President)inNeil A. Burns(Executive Officer, Director)OEOihana Elizalde(Chief Executive Officer)inBCBrian Chan(Chief Financial Officer)inKevin Gallagher(Director)

Co-investorsXEXeraya CapitalCICircular Innovation FundCOConnecticut InnovationsEMEmerald Technology Ventures AgHGHG VenturesSASafer Made+1 more

Pi-Cardia develops non-implant-based, catheter-delivered devices for treating structural heart disease, including its ShortCut product for leaflet modification.

HardwareHealthtechMedical Devices

Erez Golan(Founder)in

Co-investorsACAccelmed PartnersCLClal Biotechnology IndustriesINIndaco Venture Partners

PinCell is a biotech company developing pharmaceutical treatments in the field of dermatology, based on research into skin biology and skin disorders.

BiotechMedical Devices

CPCarlo Pincelli(CMO, Co-Founder, Co-Inventor)inAMAlessandra Marconi(Co-Founder, Co-Inventor)inAAAntonino Amato(Chairman & CEO)inBBBrydon Bennett(CSO)in

Prometheus Materials develops low-carbon cement and concrete technology, marketed as ProZERO, using algae-based biotechnology as a replacement for portland cement in ready-mix and construction applications.

CleantechConstruction TechNew MaterialsLongmont, US

LBLoren Burnett(President, CEO and Co-founder)inSCSherri Cook(Advisor and Co-founder)inMHMija Hubler(Engineering Advisor and Co-founder)inWSWil Srubar III(Technology Advisor and Co-founder)inJGJaclyn Gruber(Chief Marketing Officer)in

BoardJosko Bobanovic(Director)

Co-investorsAUAutodesk Foundation

ProQR develops medicines for patients with unmet medical needs, focusing on therapeutic development in biotech.

BiotechHealthtechMedical DevicesLeiden, NL

Co-investorsINInvivo Capital PartnersPOPontifax Venture Capital

Protera builds functional protein ingredients for the food industry using its madi platform, which combines generative AI and computational biology to design novel proteins produced through precision fermentation.

AI & Machine LearningBiotechFoodTech

Co-investorsSOSOSV

Qorium develops cell-cultured leather grown from a single animal cell sample, producing uniform collagen sheets that integrate into existing tannery and leather-goods production processes.

BiotechCircular EconomyNew Materials

Co-investorsBRBrightlands Venture PartnersINInvest-NL

Recor Medical develops the Paradise Ultrasound Renal Denervation system, a therapy that uses ultrasound technology to lower blood pressure in patients with hypertension.

BiotechHardwareHealthtechMedical DevicesPalo Alto, US

JSJacques Seguin(Director)in

BoardAndrew M. Weiss(Executive Officer, Director)APAntoine Papiernik(Executive Officer, Director)inKazumichi Kobayashi(Director)F. Thomas Watkins(Director)Frank Litvack(Director)

Co-investors41415 Capital

Redona Therapeutics is a drug discovery company co-founded by Harvard Medical School investigators focused on novel areas of biology.

AI & Machine LearningBiotechBoston, US

George Daley(Co-founder)Richard Gregory(Co-founder)Frank Slack(Co-founder)Piotr Sliz(Co-founder)inKSKazumi Shiosaki(President & CEO)in

Co-investorsASAstellas Venture Management LLCOUOUP (Osage University Partners)

Sensorion is a French clinical-stage biopharmaceutical company founded in 2009 in Montpellier that develops gene-therapy and small-molecule treatments for inner-ear disorders like genetic deafness and tinnitus.

Co-investorsINInvusREREDMILE

Provides pharmaceutical R&D services via the Cyto-Mine machine for single-cell analysis and characterisation.

Co-investors2424 HaymarketQVQVenturesPRProvidence Investment Company LimitedREREDMILE

Synthace provides a software platform for experimental design and lab automation, enabling researchers to run Design of Experiments (DOE) workflows across multiple automated laboratory instruments and devices.

AI & Machine LearningBiotechCloud ComputingDeep TechSaaS

Markus Gershater, PhD(Chief Executive Officer & Co-Founder)

Co-investors1111.2 CapitalFUFuture Planet CapitalHOHorizons VenturesUKUK Innovation & Science Seed FundAMAmadeus Capital PartnersSOSOSV

T-Therapeutics develops T cell receptor-based therapeutics for cancer and autoimmune diseases using its proprietary OpTiMus platform, which identifies antigen-specific human TCRs.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesCambridge, GB

Co-investorsCACambridge Innovation CapitalF-F-Prime CapitalSASanofi VenturesDIDigitalis Ventures

Tenpoint Therapeutics develops treatments for age-related ophthalmic conditions, with an initial focus on presbyopia care for the aging eye.

BiotechDigital HealthHealthtechLongevityMedical DevicesWarren, US

HBHENRIC BJARKE(Chief Executive Officer)in

Co-investorsADAdBio partnersF-F-Prime Capital

TISSIUM develops biomorphic polymer technology, including proprietary polymers, activation technologies, and delivery devices, to reconstruct damaged tissue and restore its function across multiple therapeutic areas.

BiotechDeep TechMedical DevicesNew Materials

CBChristophe Bancel(Co-founder & CEO)inMPMaria Pereira(Co-inventor of the technology; leads the Innovation Hub)in

Co-investorsCACathay HealthKAKaristaEUEuropean Investment BankOMOmnes Capital

Tulyp Medical develops the Tulyp System, an investigational pressure-controlled perfusion device with a microaxial pump cannula designed to restore blood flow to the leg in patients on femoral arterial support (VA-ECMO, IABP, pVAD) who are at risk of acute limb ischemia.

HardwareHealthtechMedical Devices

A biopharmaceutical company developing medicines and vaccines with a focus on clinical research and development for human health.

BiotechSan Diego, US

David Johnson(Executive Officer, Director)Cam Gallagher(Director)Scott L. Glenn(Director)in

Co-investorsCHChiesi VenturesPAPappas CapitalSOSofinnova VenturesVEVedanta CapitalARArix BioscienceOROrbiMed

Verona Pharma develops treatments for chronic lung conditions.

BiotechHealthtechLondon

Jan-Anders Karlsson(Executive Officer, Director)inPSPeter Spargo(Executive Officer)inPatrick Humphrey(Director)Ken Cunningham(Director)Kenneth Newman(Executive Officer)Anders Ullman(Director)

Co-investorsACAccess BiotechnologyAIAisling CapitalANAndera PartnersFOForesite CapitalFRFrazier Life SciencesNENew Enterprise Associates (NEA)+4 more

Women-led biotech company engineering high-performance protein-based textile fibers for fashion with sustainable alternatives to synthetic fibers.

BiotechBrooklyn, US

Valentina Gomez(Executive Officer, Director)inTSTheanne Schiros(Executive Officer)CLChui-lian Lee(Founder)in

BoardCCCorinna Chen(Director)inMKMichael Krel(Director)in

Co-investorsMAMaterial Impact